Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study

F Martinón-Torres, A Salas, I Rivero-Calle… - The lancet child & …, 2018 - thelancet.com
Background Sepsis and severe focal infections represent a substantial disease burden in
children admitted to hospital. We aimed to understand the burden of disease and outcomes …

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial

PH Muller, DMC Brinkman… - Annals of the …, 2019 - ard.bmj.com
Question Which is the best strategy to achieve (drug-free) inactive disease in juvenile
idiopathic arthritis (JIA)? Methods In a randomised, single-blinded, study in disease …

Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?

IR Klein-Wieringa, DMC Brinkman… - Current Opinion in …, 2020 - journals.lww.com
Remission can be achieved and sustained in (some) JIA patients, regardless of initial
treatment. Cornerstone principles in the management of nonsystemic JIA treatment are early …

[HTML][HTML] Reinfection with severe acute respiratory syndrome coronavirus 2 without recurrence of multisystem inflammatory syndrome in children

EP Buddingh, ACTM Vossen, HJ Lamb… - The Pediatric …, 2021 - journals.lww.com
Multisystem inflammatory syndrome in children is a rare, potentially life-threatening
postinfectious complication in children after severe acute respiratory syndrome coronavirus …

Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?

J Anink, MH Otten, SL Gorter, FHM Prince… - …, 2013 - academic.oup.com
Objectives. To evaluate differences in baseline characteristics between etanercept-and
adalimumab-treated JIA patients and to reveal factors that influence the choice between …

Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study

MJ Wahadat, D Schonenberg-Meinema… - …, 2022 - academic.oup.com
Objectives Clinical phenotyping and predicting treatment responses in SLE patients is
challenging. Extensive blood transcriptional profiling has identified various gene modules …

Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART

LBS Gelinck, CM Jol-van der Zijde… - Aids, 2009 - journals.lww.com
Design: Rabies vaccine was used as a T-cell-dependent neoantigen to investigate several
aspects of the primary and booster immune response in vivo in HIV-infected individuals …

[HTML][HTML] Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up

K Spekking, J Anink, P de Boer, SA Bergstra… - Pediatric …, 2023 - Springer
Background The aim of this study was to compare pain-scores in three targeted treatment-
strategies in JIA-patients and to identify characteristics predicting persistent pain. Methods In …

Disturbance of microbial core species in new-onset juvenile idiopathic arthritis

PH Muller, TGJ de Meij, M Westedt… - Journal of Pediatric …, 2017 - thieme-connect.com
Over the past decades, the intestinal microbiota has increasingly gained attention in studies
addressing the pathophysiology of (pediatric) autoimmune diseases, including inflammatory …

Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses

FGJ Calkoen, DMC Brinkman, C Vervat… - Cytotherapy, 2013 - Elsevier
Background aims Infusion of mesenchymal stromal cells (MSCs) has been reported to be an
effective treatment modality for acute graft-versus-host disease, and MSCs have been …